Literature DB >> 10981811

Effect of Mg2+ during reactivation and refolding of guanidine hydrochloride-denatured creatine kinase.

Y D Park1, H M Zhou.   

Abstract

Creatine kinase (ATP: creatine N-phosphotransferase, EC 2.7.3.2) was completely denatured using 3 M guanidine hydrochloride for 2 h as in previous studies [Yao et al. (1982), Sci. Sin. 25B, 1296-1302; Yao et al. (1984), Biochemistry 23, 2740-2744; Yao et al. (1982), Sci. Sin. 25B, 1186-1193]. Under suitable conditions, about 60-70% of the activity can be recovered in the presence of different Mg2+ concentrations. Both the reactivation and the refolding processes follow two-phase courses after dilution in the proper solutions. A comparison of the rate constants for the refolding of unfolded creatine kinase with those for the recovery of its catalytic activity at various Mg2+ concentrations shows that these are not synchronized. The reactivity of guanidine hydrochloride-denatured creatine kinase can be inhibited by Mg2+; however, the rates of reactivation are independent of the Mg2+ concentration. In addition, Mg2+ affects the fluorescence intensity, but the rate constants of refolding are independent of Mg2+ concentration. Although the reactivation of GdHCl-denatured creatine kinase is complete about 3 h after dilution with reactivation solutions, the conformational changes during refolding occur in a much slower reaction. Mg2+ can induce complex changes in the relative fluorescence intensity during refolding over a broad range of concentrations.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10981811     DOI: 10.1023/a:1007003703087

Source DB:  PubMed          Journal:  J Protein Chem        ISSN: 0277-8033


  30 in total

1.  Reactivation and refolding of a partially folded creatine kinase modified by 5,5'-dithio-bis(2-nitrobenzoic acid).

Authors:  Y Yang; Y D Park; T W Yu; H M Zhou
Journal:  Biochem Biophys Res Commun       Date:  1999-06-07       Impact factor: 3.575

2.  A study of the 'reactive' sulphydryl groups of adenosine 5'-triphosphate-creatine phosphotransferase.

Authors:  D C WATTS; B R RABIN
Journal:  Biochem J       Date:  1962-12       Impact factor: 3.857

3.  Inhibition of creatine kinase by iodoalkanes. Further appraisal of the essential nature of the reactive thiol group.

Authors:  S R Reddy; D C Watts
Journal:  Biochim Biophys Acta       Date:  1979-07-11

4.  Monoclonal antibody studies of creatine kinase. Antibody-binding sites in the N-terminal region of creatine kinase and effects of antibody on enzyme refolding.

Authors:  G E Morris; L C Frost; P A Newport; N Hudson
Journal:  Biochem J       Date:  1987-11-15       Impact factor: 3.857

5.  The presence of reactive SH groups in the enzymatically active dicyano derivative of creatine kinase.

Authors:  H M Zhou; C L Tsou
Journal:  Biochim Biophys Acta       Date:  1987-01-30

6.  [Active site of ATP: guanidine phosphotransferases. I. Reaction of the essential epsilon-NH2 lysine groups with 1-dimethylaminonapthalene-5-sulphonyl chloride].

Authors:  R Kassab; C Roustan; L A Pradel
Journal:  Biochim Biophys Acta       Date:  1968-10-08

7.  Comparison of activity and conformation changes during refolding of urea-denatured creatine kinase.

Authors:  H M Zhou; C L Tsou
Journal:  Biochim Biophys Acta       Date:  1986-01-17

8.  Changes in circular dichroism and exposure of buried thiol groups during denaturation of rabbit muscle creatine kinase.

Authors:  Q Z Yao; S J Liang; M Tian; C L Zou
Journal:  Sci Sin B       Date:  1985-05

9.  Studies on adenosine triphosphate transphophorylases. V. Studies on the polypeptide chains of the crystalline adenosine triphosphate-creatine transphosphorylase from rabbit skeletal muscle.

Authors:  R H Yue; R H Palmieri; O E Olson; S A Kuby
Journal:  Biochemistry       Date:  1967-10       Impact factor: 3.162

10.  Importance of the structural zinc atom for the stability of yeast alcohol dehydrogenase.

Authors:  E Magonet; P Hayen; D Delforge; E Delaive; J Remacle
Journal:  Biochem J       Date:  1992-10-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.